Revenue
2018
2019
2020
2021
2022
2023
2024
2025
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $270.3M | $224.3M | $183.0M | $138.8M | $117.1M | $131.3M | $80.3M | $64.5M |
| Gross profit | $155.5M | $133.2M | $112.8M | $84.7M | $73.4M | $80.1M | $56.0M | $47.8M |
| Research & development | $3.0M | $3.1M | $2.8M | $2.7M | $2.1M | $1.1M | $848,000 | $0 |
| Operating income | $22.9M | $17.9M | $14.3M | $8.3M | $11.6M | $26.8M | $8.9M | $10.1M |
| EBITDAderived | $51.6M | $43.3M | $36.2M | $23.9M | — | — | — | — |
| Net income | $14.9M | $11.3M | $10.2M | $6.2M | $9.1M | $31.5M | $8.5M | $9.5M |
| Basic EPSper diluted share | $0.38 | $0.29 | $0.27 | $0.16 | $0.23 | $0.81 | $0.23 | $0.25 |
| Diluted EPSper diluted share | $0.37 | $0.28 | $0.25 | $0.16 | $0.22 | $0.78 | $0.21 | $0.24 |
| Transaction | Insider | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Jun 25, 2026Form 4 | Frazier WilliamChief Medical Officer | SellCommon Shares | 10.0K | $11.72 | $117.2K | 73.2K |
| Jun 24, 2026Form 4 | Smokoff TimothyDirector | SellCommon Shares | 5.0K | $11.41 | $57.0K | 75.5K |
| Jun 24, 2026Form 4 | Smokoff TimothyDirector | SellCommon Shares | 5.0K | $11.53 | $57.6K | 80.5K |
| Jun 24, 2026Form 4 | Smokoff TimothyDirector | SellCommon Shares | 5.0K | $11.56 | $57.8K | 85.5K |
| Jun 24, 2026Form 4 | Smokoff TimothyDirector | SellCommon Shares | 3.4K | $11.50 | $38.7K | 90.5K |